HIV/AIDS Surveillance
"Detuned" HIV immunoassay detects infections missed by surveillance methods
Published in AIDS Weekly, May 23rd, 2005
"Between 1999 and 2000, new diagnoses of HIV in Victoria (Australia) rose by 41%, from 140 to 197. In this time period, sera from new HIV diagnoses were tested using the Organon Teknika 'detuned' enzyme immunoassay (EIA).
"We compared the results of the detuned EIA with incident infections defined by surveillance (on the basis of a previous negative or indeterminate HIV test and/or a seroconversion illness within the 12 months preceding HIV diagnosis)," investigators in Australia report.
"Of 317 specimens," said R.J. Guy and coworkers at the Macfarlane...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-05-23)
More Articles from AIDS Weekly
- HIV-2 Exposure
High HIV-2-specific T cell activity in HIV-2-exposed uninfected/infected persons - HIV/AIDS Drug Development
Molecular modeling reveals new HIV-1 IN binding site for nucleotide inhibitor - HIV/AIDS Vaccine
T cell vaccine might work against high- but not low-dose HIV exposure - Business & Finance
COLD-EEZE maker reports financial results - Business & Finance
Pharmaceutical company reports first quarter 2005 financial results - Business Update
Partnership to provide low-cost AIDS diagnosis and treatment monitoring - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
